(Translation) 1/4 November 16, 2020 Re: Clarification of the operating results of company and its subsidiaries for the nine months period end September 30, 2020 To: President The Stock Exchange of
www.interpharma.co.th IP_OCS/010/2562 November 10, 2019 Subject Management’s discussion and analysis for the third quarter of 2019 To President The Stock Exchange of Thailand Interpharma Public Company Limited (“the
Ref: ACC6405/001 March 12, 2021 Subject Clarification of the operating results for the quarter 1/2021 ended March 31, 2021 Attention: Director and Manager The Stock Exchange of Thailand According to
Page 1 of 3 No. ACC6308/001 August 11, 2021 Subject: Clarification of the operating results quarter 2/2021 of the year ended June 30, 2021 Attention : Director and Managing Director, The Stock
ขับเคลื่อนตลาดทุน token (Q3/2024) 1.2 Support ecosystem of investment tokens ▪ Revising regulations to facilitate sales and distribution of investment tokens ▪ Revising regulations concerning: (1
Bangkok, April 3, 2012 ? The SEC in cooperation with the Ministry of Interior, the Stock Exchange of Thailand (SET), the Federation of Thai Industries, Thai Chamber of Commerce, Investment Banking
Determination of the Date of Extraordinary General Meeting of Shareholders No. 1/2018 To: President The Stock Exchange of Thailand Enclosures: 1. Information Memorandum on the Offering of Newly Issued Ordinary
: Management explanation and analysis for the yearly ending 31 December 2018 Attention: The President of, The Stock Exchange of Thailand ZIGA Innovation Public Company Limited ( “ the Company” ) would like to
Microsoft Word - MDA Q4-2563_Eng_28 may 2020 May 27, 2020 Subject Management Discussion and Analysis for the year ended 31st March 2020 To President of the Stock Exchange of Thailand Secretary of the